ApprovalTrail

Approval · Notice of Compliance 3154 · 1998

VALPROIC SYRUP: Notice of Compliance 3154

Issued December 23, 1998

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
3154
Date
December 23, 1998
Company
Pro Doc LimiteeLaval, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to an Abbreviated New Drug Submission (SANDS), supplement
Submission class
Admin
Reason
New dosage form and strength
Therapeutic class
Anticonvulsant
Canadian reference product
DEPAKENE SYRUP (Abbott Laboratories Co.)

Products in this notice

BrandDINStatus today
VALPROIC SYRUP02239282—

Medicinal ingredients